Marvin Sih, MD
Patient Satisfaction Reviews
4.7 out of 5
Patient Comments (12)
Reviewed On 8/4/2020
IT WAS A GREAT VISIT
Reviewed On 3/20/2020
Dr. Sih is very respectful and explains my condition in detail.
Reviewed On 3/17/2020
Dr Sih is excellent! Very caring and thorough
Reviewed On 3/6/2020
really good, positive experience
Reviewed On 2/16/2020
Dr. Sih was very helpful and understanding, made the visit pleasant with much anxiety prior.
Reviewed On 2/11/2020
Reviewed On 12/20/2019
Excellent in every way.
Reviewed On 12/12/2019
[...] Dr. Sih was very professional and quickly got to the root of my problem after thorough testing, questions and answers, and back and forth conversation. Everything he said made so much sense-the lightbulb went off! Given that, it was easy to determine how to keep my problem from reoccurring. Also, the receptionist and person who took my vitals, etc. were both so courteous and professional. I never felt rushed.
Reviewed On 12/5/2019
Excellent care, excellent physician, excellent staff.
Reviewed On 11/18/2019
First visit with Dr. Sih for Parkinson's. I left with a clear understanding of the medication and timing for it. Very satisfied with the visit.
Reviewed On 10/22/2019
dr. sih is an understanding dr. that I would recommend to anyone.
Reviewed On 10/7/2019
The Dr. was one of the most caring, knowledgeable, physicians that I have seen. He listened to my concerns and examined me
- Sleep Medicine - American Board of Psychiatry and Neurology
- Neurology - American Board of Psychiatry and Neurology
Fellowship | Sleep Medicine - Neurology
Sleep Medicine - Neurology - University Of Chicago Medical Center (2012 - 2013)
Fellowship | Neurophysiology
Neurophysiology - University Of Chicago Medical Center (2011 - 2012)
Residency | Neurology
Neurology - University Of Chicago Medical Center (2008 - 2011)
Internship | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (2007 - 2008)
University Of The Philippines Manila College Of Medicine (2005)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Marvin Sih did not disclose any Outside Relationships with Industry.